logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5115.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5115.produseast1
World Refugee Day 2022 | Collections | MSF Science Portal
World Refugee Day 2022

World Refugee Day 2022

As we mark World Refugee Day (20 June 2022), over 100 million people globally are forcibly displaced from their home—the highest number ever recorded, according to the United Nations Refugee Agency. The health impacts of this displacement are dire: millions of people exposed to violence, infectious disease, and exclusion from health care during often-treacherous journeys or in detention centers and refugee camps.


Here we bring you a selection of MSF research aimed at better understanding and meeting the medical needs of populations along their migration route. Some studies describe the physical and psychological wounds our teams witness among specific populations—from unaccompanied minors to people detained under inhumane conditions in Libya or rescued from drowning after risking everything in perilous Mediterranean Sea crossings. Others assess ways to improve models of care for refugees with chronic diseases like hypertension and diabetes, or for tackling infectious diseases such as diphtheria and hepatitis E in overcrowded, unhygienic camps.

Collection Content

Conference Material
|
Slide Presentation

Fixed dose combination drugs for cardiovascular disease in Lebanon

Ansbro E, Masri S, Prieto-Merino D, Bahous SA, Molfino L,  et al.
2022-05-11 • MSF Scientific Days International 2022
2022-05-11 • MSF Scientific Days International 2022
Journal Article
|
Research

Health conditions of migrants, refugees and asylum seekers on search and rescue vessels on the central Mediterranean Sea, 2016-2019: a retrospective analysis

Van Boetzelaer E, Fotso A, Angelova I, Huisman G, Thorson T,  et al.
2022-01-11 • BMJ Open
2022-01-11 • BMJ Open
OBJECTIVES
This study will contribute to the systematic epidemiological description of morbidities among migrants, refugees and asylum seekers when crossing the Mediterranean Sea.
Journal Article
|
Research

Seroprevalence of SARS-CoV-2 antibodies and retrospective mortality in a refugee camp, Dagahaley, Kenya

Gignoux EM, Athanassiadis F, Garat Yarrow A, Jimale A, Mubuto N,  et al.
2021-12-17 • PLOS One
2021-12-17 • PLOS One
BACKGROUND
Camps of forcibly displaced populations are considered to be at risk of large COVID-19 outbreaks. Low screening rates and limited surveillance led us to conduct a study in...
Journal Article
|
Research

A qualitative exploration of post-migration stressors and psychosocial well-being in two asylum reception centres in Belgium

Whitehouse K, Lambe E, Rodriguez S, Pellecchia U, Ponthieu A,  et al.
2021-08-01 • International Journal of Migration, Health and Social Care
2021-08-01 • International Journal of Migration, Health and Social Care
PURPOSE
Prolonged exposure to daily stressors can have long-term detrimental implications for overall mental health. For asylum seekers in European Union transit or destination count...
Journal Article
|
Research

The effect of home-based care on housebound patients and their caregivers in two Palestinian refugee camps in Lebanon: a qualitative study

Sunallah M, van den Boogaard W, Lakis C, Rinchey L, Saavedra L
2021-07-01 • Lancet
2021-07-01 • Lancet
BACKGROUND
The incidence of non-communicable diseases (NCDs) increases annually by approximately 5% among older (age 50 years and older) Palestinian refugees in Lebanon, of whom arou...
Journal Article
|
Research

Health of migrants, refugees and asylum seekers in detention in Tripoli, Libya, 2018-2019: Retrospective analysis of routine medical programme data

Kuehne A, Van Boetzelaer E, Alfani P, Fotso A, Elhammali H,  et al.
2021-06-04 • PLOS One
2021-06-04 • PLOS One
Libya is a major transit and destination country for international migration. UN agencies estimates 571,464 migrants, refugees and asylum seekers in Libya in 2021; among these, 3,934 peo...
Journal Article
|
Research

Migrant children in transit: health profile and social needs of unaccompanied and accompanied children visiting the MSF clinic in Belgrade, Serbia

Topalovic T, Episkopou M, Schillberg EBL, Brcanski J, Jocic M
2021-04-29 • Conflict and Health
2021-04-29 • Conflict and Health
BACKGROUND
Thousands of children migrate to Europe each year in search of safety and the promise of a better life. Many of them transited through Serbia in 2018. Children journey alo...
Journal Article
|
Research

Epidemiological, clinical, and public health response characteristics of a large outbreak of diphtheria among the Rohingya population in Cox's Bazar, Bangladesh, 2017 to 2019: A retrospective study

Polonsky JA, Ivey M, Mazhar KA, Rahman Z, le Polain de Waroux O,  et al.
2021-04-01 • PLOS Medicine
2021-04-01 • PLOS Medicine
BACKGROUND
Unrest in Myanmar in August 2017 resulted in the movement of over 700,000 Rohingya refugees to overcrowded camps in Cox's Bazar, Bangladesh. A large outbreak of diphtheria...
Journal Article
|
Commentary

Roles and responsibilities of cultural mediators

Venables E, Whitehouse K, Spissu C, Pizzi L, Al Rousan A,  et al.
2021-03-01 • Forced Migration Review
2021-03-01 • Forced Migration Review
Journal Article
|
Research

Clinical outcomes in a primary-level non-communicable disease programme for Syrian refugees and the host population in Jordan: A cohort analysis using routine data

Ansbro É, Homan T, Jobanputra K, Qasem J, Muhammad S,  et al.
2021-01-11 • PLOS Medicine
2021-01-11 • PLOS Medicine
BACKGROUND
Little is known about the content or quality of non-communicable disease (NCD) care in humanitarian settings. Since 2014, Médecins Sans Frontières (MSF) has provided prima...

See more collections

ASTMH Annual Meeting 2024

ASTMH Annual Meeting 2024

The American Society of Tropical Medicine & Hygiene (ASTMH) Annual Meeting is an international forum for the exchange of scientific and clinical advances in tropical medicine, hygiene and global health. The scientific content this year is 53% microbe focused, 15% clinically focused, 13% vector focused, 13% globally focused, and 6% intervention focused.

MSF and Epicentre are presenting on access and other challenges for children with visceral and cutaneous leishmaniasis, hurdles in malaria diagnostic testing, and ensuring equitable access to healthcare in conversations about financial sustainability.

This collection features research authored by the presenters and other topics highlighted at ASTMH.

Safe abortion care at MSF

Safe abortion care at MSF

Unsafe abortion is a major cause of maternal death, and the only one that is completely preventable. Yet over 30 million unsafe abortions occur each year, leading to at least 29,000 deaths and millions of serious complications—nearly all in low- and middle-income countries. MSF teams see these tragic consequences first-hand, treating thousands of patients every year with severe, potentially life-threatening effects from unsafe abortion.


To mark International Safe Abortion Awareness Day (28 September 2024), this Collection presents highlights of MSF’s work on safe abortion care (SAC) as a way to reduce maternal death and injury. By re-assessing and reshaping how our projects deliver SAC in fragile and conflict-affected settings, we have been able to significantly expand services in those contexts and across MSF projects globally. In parallel, we also conducted in-depth studies of abortion complications and their contributing factors in fragile settings, where a dearth of evidence limits understanding of women's needs in accessing comprehensive care. These findings are helping to identify gaps in service delivery and inform operational decision-making.

Expanding access to lifesaving new TB tools

Expanding access to lifesaving new TB tools
Many settings with a high burden of drug-resistant tuberculosis (DR-TB) lack access to advanced diagnostics and to groundbreaking new treatments. The Collection linked below spotlights work by MSF and collaborators to analyze barriers, identify gaps, and accelerate the roll-out of these tools to people whose lives hang in the balance. Several reports examine price, regulatory, and patent obstacles that persist despite considerable public investment into developing many of these tools. Other authors examine critical remaining weaknesses in care pathways—especially in screening and diagnosis, and particularly in children. Several studies describe new strategies that could be part of the solution, from a pilot program in Tajikisttan that trains family caregivers to treat children with DR-TB at home, to a person-centered care model adapted to a conflict zone in Afghanistan. Lastly, initial findings demonstrate that pregnant women—another vulnerable population—can be effectively treated for DR- and multidrug-resistant TB, improving maternal outcomes without harming neonates.
View All Collections